Cita APA

Armand, P., Engert, A., Younes, A., Fanale, M., Santoro, A., Zinzani, P. L., . . . Ansell, S. M. (2018). Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial. J Clin Oncol.

Chicago Style Citation

Armand, Philippe, et al. "Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial." J Clin Oncol 2018.

Cita MLA

Armand, Philippe, et al. "Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial." J Clin Oncol 2018.